https://www.pharmadoc.it/wp-content/uploads/2019/02/Copia-di-DM.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-02-14 11:35:392019-02-14 11:35:39D.M. 10.08.2018: le linee guida per le procedure di acquisto di dispositivi medici
https://www.pharmadoc.it/wp-content/uploads/2019/02/Public-Health.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-02-07 13:19:402019-02-07 13:19:40La programmazione AIFA per il 2019. Si prefigura uno “scossone” al sistema-farmaco
https://www.pharmadoc.it/wp-content/uploads/2019/01/Fattore-VIII.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-01-30 15:06:212019-05-23 15:11:35Fattore VIII e lotto unico – Il Consiglio di Stato tiene in piedi la gara
https://www.pharmadoc.it/wp-content/uploads/2019/01/Accordo-quadro-garesito.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-01-10 12:04:092019-05-23 15:08:53Gare per biosimilari prevale l’utilizzo dell’accordo quadro. Il caso delle epoetine.
https://www.pharmadoc.it/wp-content/uploads/2019/01/File-F-sito.jpg
1280
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-01-07 10:36:562019-01-07 10:37:59File F: tra spesa farmaceutica e innovazione terapeutica
https://www.pharmadoc.it/wp-content/uploads/2018/12/Corte-di-Giustizia-dellUnione-europea-Lussemburgo.jpg
1166
1495
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2018-11-22 09:53:592019-05-23 14:59:14Nuova pronuncia della Corte di Giustizia UE a favore dell’uso off-label di Avastin
https://www.pharmadoc.it/wp-content/uploads/2018/12/Generici-biosimilari.jpg
1000
2000
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2018-10-15 17:07:122019-10-29 15:30:55Biosimilari: il Position Paper di Farmindustria